These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11073167)

  • 1. Incidence of chronic myeloproliferative disorders in the city of Göteborg, Sweden 1983-1992.
    Ridell B; Carneskog J; Wedel H; Vilén L; Høgh Dufva I; Mellqvist UH; Brywe N; Wadenvik H; Kutti J
    Eur J Haematol; 2000 Oct; 65(4):267-71. PubMed ID: 11073167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis.
    Kutti J; Ridell B
    Pathol Biol (Paris); 2001 Mar; 49(2):164-6. PubMed ID: 11317963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99.
    Johansson P; Kutti J; Andréasson B; Safai-Kutti S; Vilén L; Wedel H; Ridell B
    J Intern Med; 2004 Aug; 256(2):161-5. PubMed ID: 15257729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.
    Landgren O; Goldin LR; Kristinsson SY; Helgadottir EA; Samuelsson J; Björkholm M
    Blood; 2008 Sep; 112(6):2199-204. PubMed ID: 18451307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea.
    Lim Y; Lee JO; Bang SM
    J Korean Med Sci; 2016 Oct; 31(10):1579-85. PubMed ID: 27550486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011.
    Deadmond MA; Smith-Gagen JA
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2131-8. PubMed ID: 25968903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union.
    Moulard O; Mehta J; Fryzek J; Olivares R; Iqbal U; Mesa RA
    Eur J Haematol; 2014 Apr; 92(4):289-97. PubMed ID: 24372927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the incidence and overall survival of patients with myeloproliferative neoplasms between 2002 and 2016 in the United States.
    Verstovsek S; Yu J; Scherber RM; Verma S; Dieyi C; Chen CC; Parasuraman S
    Leuk Lymphoma; 2022 Mar; 63(3):694-702. PubMed ID: 34689695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiologic features of Philadelphia-negative chronic myeloproliferative disorders in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 33-year period].
    Jakó J; Szerafin L
    Orv Hetil; 2017 Apr; 158(15):572-578. PubMed ID: 28393599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How common are myeloproliferative neoplasms? A systematic review and meta-analysis.
    Titmarsh GJ; Duncombe AS; McMullin MF; O'Rorke M; Mesa R; De Vocht F; Horan S; Fritschi L; Clarke M; Anderson LA
    Am J Hematol; 2014 Jun; 89(6):581-7. PubMed ID: 24971434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada.
    Heppner J; Nguyen LT; Guo M; Naugler C; Rashid-Kolvear F
    BMC Res Notes; 2019 May; 12(1):286. PubMed ID: 31126326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemic transformation in patients with myeloproliferative neoplasms: a population-based retrospective study.
    Shrestha R; Giri S; Armitage JO; Bhatt VR
    Future Oncol; 2017 Jun; 13(14):1239-1246. PubMed ID: 28589759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of the myeloproliferative disorders polycythemia vera and essential thrombocythemia.
    Johansson P
    Semin Thromb Hemost; 2006 Apr; 32(3):171-3. PubMed ID: 16673273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classic myeloproliferative neoplasms in Singapore: A population-based study on incidence, trends, and survival from 1968 to 2017.
    Htun HL; Lian W; Wong J; Tan EJ; Foo LL; Ong KH; Lim WY
    Cancer Epidemiol; 2022 Aug; 79():102175. PubMed ID: 35569302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
    Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
    Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria.
    Yassin MA; Taher A; Mathews V; Hou HA; Shamsi T; Tuğlular TF; Xiao Z; Kim SJ; Depei W; Li J; Rippin G; Sadek I; Siddiqui A; Wong RS
    Cancer Med; 2020 Jul; 9(13):4512-4526. PubMed ID: 32351024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An addition to geographic hematology: chronic myeloproliferative diseases are infrequent in Mexican Mestizos.
    Ruiz-Argüelles GJ; López-Martínez B; Lobato-Mendizábal E; Ruiz-Delgado GJ
    Int J Hematol; 2002 Jun; 75(5):499-502. PubMed ID: 12095150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-Pathological Profile And Outcomes Of Patients With Polycythaemia Vera, Essential Thrombocythaemia And Idiopathic Myelofibrosis: A Tertiary Care Center Experience From Southern Pakistan.
    Shaikh MS; Shaikh MU; Adil SN; Khurshid M; Ahmed ZA
    J Ayub Med Coll Abbottabad; 2016; 28(2):293-297. PubMed ID: 28718562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.